カテゴリー： GlobalInfoResearch, 世界

組換えベクターワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Recombinant Vector Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9101143）・商品コード：GIR9101143
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月9日（※2024年版があります。お問い合わせください）
・ページ数：120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、組換えベクターワクチンの世界市場について調べ、まとめました。種類別セグメントは、水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他等、用途別セグメントは、大人用、子供用等に区分しました。組換えベクターワクチンの世界市場概観、メーカー動向、メーカー別組換えベクターワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・組換えベクターワクチンの市場概観
・組換えベクターワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・組換えベクターワクチンの企業別販売動向、市場シェア、市場集中度、競争動向
・組換えベクターワクチンの世界市場規模
・組換えベクターワクチンの北米市場分析（アメリカ、カナダ、メキシコ等）
・組換えベクターワクチンのアメリカ市場規模推移
・組換えベクターワクチンのカナダ市場規模推移
・組換えベクターワクチンのメキシコ市場規模推移
・組換えベクターワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・組換えベクターワクチンのドイツ市場規模推移
・組換えベクターワクチンのイギリス市場規模推移
・組換えベクターワクチンのロシア市場規模推移
・組換えベクターワクチンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・組換えベクターワクチンの日本市場規模推移
・組換えベクターワクチンの中国市場規模推移
・組換えベクターワクチンの韓国市場規模推移
・組換えベクターワクチンのインド市場規模推移
・組換えベクターワクチンの東南アジア市場規模推移
・組換えベクターワクチンの南米市場分析（ブラジル、アルゼンチン等）
・組換えベクターワクチンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・組換えベクターワクチンの種類別分析/販売量、売上、市場シェア（水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他）
・組換えベクターワクチンの用途別分析/市場規模（大人用、子供用）
・組換えベクターワクチンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・組換えベクターワクチンの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Recombinant vector vaccines are experimental vaccines similar to DNA vaccines, but they use an attenuated virus or bacterium to introduce microbial DNA to cells of the body. “Vector” refers to the virus or bacterium used as the carrier.
In nature, viruses latch on to cells and inject their genetic material into them. In the lab, scientists have taken advantage of this process. They have figured out how to take the roomy genomes of certain harmless or attenuated viruses and insert portions of the genetic material from other microbes into them. The carrier viruses then ferry that microbial DNA to cells. Recombinant vector vaccines closely mimic a natural infection and therefore do a good job of stimulating the immune system.
Attenuated bacteria also can be used as vectors. In this case, the inserted genetic material causes the bacteria to display the antigens of other microbes on its surface. In effect, the harmless bacterium mimics a harmful microbe, provoking an immune response.
Researchers are working on both bacteria-l and viral-based recombinant vector vaccines for HIV, rabies, and measles.

Scope of the Report:
The worldwide market for Recombinant Vector Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Recombinant Vector Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
SANOFI PASTEUR S.A.
Novartis
GSK
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Others

Market Segment by Applications, can be divided into
For Adult
For Child

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Recombinant Vector Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Recombinant Vector Vaccines, with price, sales, revenue and global market share of Recombinant Vector Vaccines in 2017 and 2018.
Chapter 3, the Recombinant Vector Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Recombinant Vector Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Recombinant Vector Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Recombinant Vector Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Recombinant Vector Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Varicella
1.2.2 Influenza
1.2.3 Polio
1.2.4 Hepatitis A
1.2.5 Rabies
1.2.6 BCG
1.2.7 Hepatitis B
1.2.8 Pertussis, Diphtheria, tetanus
1.2.9 Pneumococcal
1.2.10 Others
1.3 Market Analysis by Applications
1.3.1 For Adult
1.3.2 For Child
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 SANOFI PASTEUR S.A.
2.1.1 Business Overview
2.1.2 Recombinant Vector Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Recombinant Vector Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 GSK
2.3.1 Business Overview
2.3.2 Recombinant Vector Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GSK Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 CNBG
2.4.1 Business Overview
2.4.2 Recombinant Vector Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 CNBG Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 ChengDa Bio
2.5.1 Business Overview
2.5.2 Recombinant Vector Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 ChengDa Bio Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Changsheng Life
2.6.1 Business Overview
2.6.2 Recombinant Vector Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Changsheng Life Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Zhifei
2.7.1 Business Overview
2.7.2 Recombinant Vector Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Zhifei Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 SINOVAC BIOTECH
2.8.1 Business Overview
2.8.2 Recombinant Vector Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 SINOVAC BIOTECH Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 NuoCheng Bio
2.9.1 Business Overview
2.9.2 Recombinant Vector Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 NuoCheng Bio Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Hualan Bio
2.10.1 Business Overview
2.10.2 Recombinant Vector Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Hualan Bio Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Kangtai
2.11.1 Business Overview
2.11.2 Recombinant Vector Vaccines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Kangtai Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Recombinant Vector Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Recombinant Vector Vaccines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Recombinant Vector Vaccines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Recombinant Vector Vaccines Manufacturer Market Share in 2018
3.3.2 Top 6 Recombinant Vector Vaccines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Recombinant Vector Vaccines Market Analysis by Regions
4.1 Global Recombinant Vector Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Recombinant Vector Vaccines Sales and Market Share by Regions (2014-2019)
4.1.2 Global Recombinant Vector Vaccines Revenue and Market Share by Regions (2014-2019)
4.2 North America Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
4.3 Europe Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
4.5 South America Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
5 North America Recombinant Vector Vaccines by Country
5.1 North America Recombinant Vector Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Recombinant Vector Vaccines Sales and Market Share by Country (2014-2019)
5.1.2 North America Recombinant Vector Vaccines Revenue and Market Share by Country (2014-2019)
5.2 United States Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
5.3 Canada Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
5.4 Mexico Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
6 Europe Recombinant Vector Vaccines by Country
6.1 Europe Recombinant Vector Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Recombinant Vector Vaccines Sales and Market Share by Country (2014-2019)
6.1.2 Europe Recombinant Vector Vaccines Revenue and Market Share by Country (2014-2019)
6.2 Germany Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
6.3 UK Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
6.4 France Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
6.5 Russia Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
6.6 Italy Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Recombinant Vector Vaccines by Country
7.1 Asia-Pacific Recombinant Vector Vaccines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Recombinant Vector Vaccines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Recombinant Vector Vaccines Revenue and Market Share by Country (2014-2019)
7.2 China Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
7.3 Japan Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
7.4 Korea Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
7.5 India Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
8 South America Recombinant Vector Vaccines by Country
8.1 South America Recombinant Vector Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Recombinant Vector Vaccines Sales and Market Share by Country (2014-2019)
8.1.2 South America Recombinant Vector Vaccines Revenue and Market Share by Country (2014-2019)
8.2 Brazil Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
8.3 Argentina Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
8.4 Colombia Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Recombinant Vector Vaccines by Countries
9.1 Middle East and Africa Recombinant Vector Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Recombinant Vector Vaccines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Recombinant Vector Vaccines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
9.3 Turkey Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
9.4 Egypt Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
9.5 Nigeria Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
9.6 South Africa Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
10 Global Recombinant Vector Vaccines Market Segment by Type
10.1 Global Recombinant Vector Vaccines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Recombinant Vector Vaccines Sales and Market Share by Type (2014-2019)
10.1.2 Global Recombinant Vector Vaccines Revenue and Market Share by Type (2014-2019)
10.2 Varicella Sales Growth and Price
10.2.1 Global Varicella Sales Growth (2014-2019)
10.2.2 Global Varicella Price (2014-2019)
10.3 Influenza Sales Growth and Price
10.3.1 Global Influenza Sales Growth (2014-2019)
10.3.2 Global Influenza Price (2014-2019)
10.4 Polio Sales Growth and Price
10.4.1 Global Polio Sales Growth (2014-2019)
10.4.2 Global Polio Price (2014-2019)
10.5 Hepatitis A Sales Growth and Price
10.5.1 Global Hepatitis A Sales Growth (2014-2019)
10.5.2 Global Hepatitis A Price (2014-2019)
10.6 Rabies Sales Growth and Price
10.6.1 Global Rabies Sales Growth (2014-2019)
10.6.2 Global Rabies Price (2014-2019)
10.7 BCG Sales Growth and Price
10.7.1 Global BCG Sales Growth (2014-2019)
10.7.2 Global BCG Price (2014-2019)
10.8 Hepatitis B Sales Growth and Price
10.8.1 Global Hepatitis B Sales Growth (2014-2019)
10.8.2 Global Hepatitis B Price (2014-2019)
10.9 Pertussis, Diphtheria, tetanus Sales Growth and Price
10.9.1 Global Pertussis, Diphtheria, tetanus Sales Growth (2014-2019)
10.9.2 Global Pertussis, Diphtheria, tetanus Price (2014-2019)
10.10 Pneumococcal Sales Growth and Price
10.10.1 Global Pneumococcal Sales Growth (2014-2019)
10.10.2 Global Pneumococcal Price (2014-2019)
10.11 Others Sales Growth and Price
10.11.1 Global Others Sales Growth (2014-2019)
10.11.2 Global Others Price (2014-2019)
11 Global Recombinant Vector Vaccines Market Segment by Application
11.1 Global Recombinant Vector Vaccines Sales Market Share by Application (2014-2019)
11.2 For Adult Sales Growth (2014-2019)
11.3 For Child Sales Growth (2014-2019)
12 Recombinant Vector Vaccines Market Forecast (2019-2024)
12.1 Global Recombinant Vector Vaccines Sales, Revenue and Growth Rate (2019-2024)
12.2 Recombinant Vector Vaccines Market Forecast by Regions (2019-2024)
12.2.1 North America Recombinant Vector Vaccines Market Forecast (2019-2024)
12.2.2 Europe Recombinant Vector Vaccines Market Forecast (2019-2024)
12.2.3 Asia-Pacific Recombinant Vector Vaccines Market Forecast (2019-2024)
12.2.4 South America Recombinant Vector Vaccines Market Forecast (2019-2024)
12.2.5 Middle East and Africa Recombinant Vector Vaccines Market Forecast (2019-2024)
12.3 Recombinant Vector Vaccines Market Forecast by Type (2019-2024)
12.3.1 Global Recombinant Vector Vaccines Sales Forecast by Type (2019-2024)
12.3.2 Global Recombinant Vector Vaccines Market Share Forecast by Type (2019-2024)
12.4 Recombinant Vector Vaccines Market Forecast by Application (2019-2024)
12.4.1 Global Recombinant Vector Vaccines Sales Forecast by Application (2019-2024)
12.4.2 Global Recombinant Vector Vaccines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Recombinant Vector Vaccines Picture
Table Product Specifications of Recombinant Vector Vaccines
Figure Global Sales Market Share of Recombinant Vector Vaccines by Types in 2018
Table Recombinant Vector Vaccines Types for Major Manufacturers
Figure Varicella Picture
Figure Influenza Picture
Figure Polio Picture
Figure Hepatitis A Picture
Figure Rabies Picture
Figure BCG Picture
Figure Hepatitis B Picture
Figure Pertussis, Diphtheria, tetanus Picture
Figure Pneumococcal Picture
Figure Others Picture
Figure Recombinant Vector Vaccines Sales Market Share by Applications in 2018
Figure For Adult Picture
Figure For Child Picture
Figure United States Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure France Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure UK Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure China Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure India Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Recombinant Vector Vaccines Revenue (Value) and Growth Rate (2014-2024)
Table SANOFI PASTEUR S.A. Basic Information, Manufacturing Base and Competitors
Table SANOFI PASTEUR S.A. Recombinant Vector Vaccines Type and Applications
Table SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Recombinant Vector Vaccines Type and Applications
Table Novartis Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Recombinant Vector Vaccines Type and Applications
Table GSK Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CNBG Basic Information, Manufacturing Base and Competitors
Table CNBG Recombinant Vector Vaccines Type and Applications
Table CNBG Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table ChengDa Bio Basic Information, Manufacturing Base and Competitors
Table ChengDa Bio Recombinant Vector Vaccines Type and Applications
Table ChengDa Bio Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Changsheng Life Basic Information, Manufacturing Base and Competitors
Table Changsheng Life Recombinant Vector Vaccines Type and Applications
Table Changsheng Life Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Zhifei Basic Information, Manufacturing Base and Competitors
Table Zhifei Recombinant Vector Vaccines Type and Applications
Table Zhifei Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table SINOVAC BIOTECH Basic Information, Manufacturing Base and Competitors
Table SINOVAC BIOTECH Recombinant Vector Vaccines Type and Applications
Table SINOVAC BIOTECH Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table NuoCheng Bio Basic Information, Manufacturing Base and Competitors
Table NuoCheng Bio Recombinant Vector Vaccines Type and Applications
Table NuoCheng Bio Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio Recombinant Vector Vaccines Type and Applications
Table Hualan Bio Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Kangtai Basic Information, Manufacturing Base and Competitors
Table Kangtai Recombinant Vector Vaccines Type and Applications
Table Kangtai Recombinant Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Recombinant Vector Vaccines Sales by Manufacturer (2017-2018)
Figure Global Recombinant Vector Vaccines Sales Market Share by Manufacturer in 2017
Figure Global Recombinant Vector Vaccines Sales Market Share by Manufacturer in 2018
Table Global Recombinant Vector Vaccines Revenue by Manufacturer (2017-2018)
Figure Global Recombinant Vector Vaccines Revenue Market Share by Manufacturer in 2017
Figure Global Recombinant Vector Vaccines Revenue Market Share by Manufacturer in 2018
Figure Top 3 Recombinant Vector Vaccines Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Recombinant Vector Vaccines Manufacturer (Revenue) Market Share in 2018
Figure Global Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Global Recombinant Vector Vaccines Revenue and Growth Rate (2014-2019)
Table Global Recombinant Vector Vaccines Sales by Regions (2014-2019)
Table Global Recombinant Vector Vaccines Sales Market Share by Regions (2014-2019)
Table Global Recombinant Vector Vaccines Revenue by Regions (2014-2019)
Figure Global Recombinant Vector Vaccines Revenue Market Share by Regions in 2014
Figure Global Recombinant Vector Vaccines Revenue Market Share by Regions in 2018
Figure North America Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Europe Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure South America Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure North America Recombinant Vector Vaccines Revenue and Growth Rate (2014-2019)
Table North America Recombinant Vector Vaccines Sales by Countries (2014-2019)
Table North America Recombinant Vector Vaccines Sales Market Share by Countries (2014-2019)
Figure North America Recombinant Vector Vaccines Sales Market Share by Countries in 2014
Figure North America Recombinant Vector Vaccines Sales Market Share by Countries in 2018
Table North America Recombinant Vector Vaccines Revenue by Countries (2014-2019)
Table North America Recombinant Vector Vaccines Revenue Market Share by Countries (2014-2019)
Figure North America Recombinant Vector Vaccines Revenue Market Share by Countries in 2014
Figure North America Recombinant Vector Vaccines Revenue Market Share by Countries in 2018
Figure United States Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Canada Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Mexico Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Europe Recombinant Vector Vaccines Revenue and Growth Rate (2014-2019)
Table Europe Recombinant Vector Vaccines Sales by Countries (2014-2019)
Table Europe Recombinant Vector Vaccines Sales Market Share by Countries (2014-2019)
Table Europe Recombinant Vector Vaccines Revenue by Countries (2014-2019)
Figure Europe Recombinant Vector Vaccines Revenue Market Share by Countries in 2017
Figure Europe Recombinant Vector Vaccines Revenue Market Share by Countries in 2018
Figure Germany Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure UK Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure France Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Russia Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Italy Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Recombinant Vector Vaccines Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Recombinant Vector Vaccines Sales by Countries (2014-2019)
Table Asia-Pacific Recombinant Vector Vaccines Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Recombinant Vector Vaccines Sales Market Share by Countries 2018
Table Asia-Pacific Recombinant Vector Vaccines Revenue by Countries (2014-2019)
Figure Asia-Pacific Recombinant Vector Vaccines Revenue Market Share by Countries 2018
Figure China Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Japan Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Korea Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure India Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Southeast Asia Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure South America Recombinant Vector Vaccines Revenue and Growth Rate (2014-2019)
Table South America Recombinant Vector Vaccines Sales by Countries (2014-2019)
Table South America Recombinant Vector Vaccines Sales Market Share by Countries (2014-2019)
Figure South America Recombinant Vector Vaccines Sales Market Share by Countries in 2018
Table South America Recombinant Vector Vaccines Revenue by Countries (2014-2019)
Table South America Recombinant Vector Vaccines Revenue Market Share by Countries (2014-2019)
Figure South America Recombinant Vector Vaccines Revenue Market Share by Countries in 2018
Figure Brazil Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Argentina Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Colombia Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Recombinant Vector Vaccines Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Recombinant Vector Vaccines Sales by Countries (2014-2019)
Table Middle East and Africa Recombinant Vector Vaccines Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Vector Vaccines Sales Market Share by Countries in 2018
Table Middle East and Africa Recombinant Vector Vaccines Revenue by Countries (2014-2019)
Table Middle East and Africa Recombinant Vector Vaccines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Recombinant Vector Vaccines Revenue Market Share by Countries in 2014
Figure Middle East and Africa Recombinant Vector Vaccines Revenue Market Share by Countries in 2018
Figure Saudi Arabia Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure UAE Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Egypt Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure Nigeria Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Figure South Africa Recombinant Vector Vaccines Sales and Growth Rate (2014-2019)
Table Global Recombinant Vector Vaccines Sales by Type (2014-2019)
Table Global Recombinant Vector Vaccines Sales Share by Type (2014-2019)
Table Global Recombinant Vector Vaccines Revenue by Type (2014-2019)
Table Global Recombinant Vector Vaccines Revenue Share by Type (2014-2019)
Figure Global Varicella Sales Growth (2014-2019)
Figure Global Varicella Price (2014-2019)
Figure Global Influenza Sales Growth (2014-2019)
Figure Global Influenza Price (2014-2019)
Figure Global Polio Sales Growth (2014-2019)
Figure Global Polio Price (2014-2019)
Figure Global Hepatitis A Sales Growth (2014-2019)
Figure Global Hepatitis A Price (2014-2019)
Figure Global Rabies Sales Growth (2014-2019)
Figure Global Rabies Price (2014-2019)
Figure Global BCG Sales Growth (2014-2019)
Figure Global BCG Price (2014-2019)
Figure Global Hepatitis B Sales Growth (2014-2019)
Figure Global Hepatitis B Price (2014-2019)
Figure Global Pertussis, Diphtheria, tetanus Sales Growth (2014-2019)
Figure Global Pertussis, Diphtheria, tetanus Price (2014-2019)
Figure Global Pneumococcal Sales Growth (2014-2019)
Figure Global Pneumococcal Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Recombinant Vector Vaccines Sales by Application (2014-2019)
Table Global Recombinant Vector Vaccines Sales Share by Application (2014-2019)
Figure Global For Child Sales Growth (2014-2019)
Figure Global Recombinant Vector Vaccines Sales, Revenue and Growth Rate (2019-2024)
Table Global Recombinant Vector Vaccines Sales Forecast by Regions (2019-2024)
Table Global Recombinant Vector Vaccines Market Share Forecast by Regions (2019-2024)
Figure North America Sales Recombinant Vector Vaccines Market Forecast (2019-2024)
Figure Europe Sales Recombinant Vector Vaccines Market Forecast (2019-2024)
Figure Asia-Pacific Sales Recombinant Vector Vaccines Market Forecast (2019-2024)
Figure South America Sales Recombinant Vector Vaccines Market Forecast (2019-2024)
Figure Middle East and Africa Sales Recombinant Vector Vaccines Market Forecast (2019-2024)
Table Global Recombinant Vector Vaccines Sales Forecast by Type (2019-2024)
Table Global Recombinant Vector Vaccines Market Share Forecast by Type (2019-2024)
Table Global Recombinant Vector Vaccines Sales Forecast by Application (2019-2024)
Table Global Recombinant Vector Vaccines Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List


【掲載企業】

SANOFI PASTEUR S.A.、Novartis、GSK、CNBG、ChengDa Bio、Changsheng Life、Zhifei、SINOVAC BIOTECH、NuoCheng Bio、Hualan Bio、Kangtai、

★調査レポート[組換えベクターワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9101143)販売に関する免責事項を必ずご確認ください。
★調査レポート[組換えベクターワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 猫用ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101182 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、猫用ワクチンの世界市場について調べ、まとめました。種類別セグメントは、弱毒生ワクチン、コンジュゲートワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン等、用途別セグメントは、＜6ヶ月、≥6ヶ月等に区分しました。猫用ワクチンの世界市場概観、メーカー動向、メーカー別猫用ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・猫用ワクチンの市場概観 ・猫用ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・猫用ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・猫用ワクチンの世界市場規模 ・猫用ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・猫用ワクチンのアメリカ市場規模推移 ・猫用ワクチンのカナダ市場規模推移 ・猫用ワクチンのメキシコ市場規模推移 ・猫用ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for cats Scope of the Report: The worldwide market for Cat Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study....
  • 犬用ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101183 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、犬用ワクチンの世界市場について調べ、まとめました。種類別セグメントは、弱毒生ワクチン、コンジュゲートワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン等、用途別セグメントは、...A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs Scope of the Report: The worldwide market for Dog Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study....
  • 小児ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100436 / GlobalInfoResearch / 2019年10月11日 / 本調査レポートは、小児ワクチンの世界市場について調べ、まとめました。種類別セグメントは、組換えワクチン、ウイルスワクチン、多糖ワクチン、その他等、用途別セグメントは、病院、クリニック等に区分しました。小児ワクチンの世界市場概観、メーカー動向、メーカー別小児ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・小児ワクチンの市場概観 ・小児ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・小児ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・小児ワクチンの世界市場規模 ・小児ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・小児ワクチンのアメリカ市場規模推移 ・小児ワクチンのカナダ市場規模推移 ・小児ワクチンのメキシコ市場規模推移 ・小児ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Childhood Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Childhood Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers MedImmune LLC J&J(Crucell) Pfizer Sanofi GSK Merck Tiantan CSL Jintan...
  • ベクトル信号アナライザーの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102145 / GlobalInfoResearch / 2019年9月17日 / 本調査レポートは、ベクトル信号アナライザーの世界市場について調べ、まとめました。種類別セグメントは、ハンドヘルドアナライザー、ポータブルアナライザー、ベンチトップアナライザー等、用途別セグメントは、エレクトロニクスおよび半導体、ITおよび通信、航空宇宙および防衛、自動車および輸送、ヘルスケア等に区分しました。ベクトル信号アナライザーの世界市場概観、メーカー動向、メーカー別ベクトル信号アナライザーシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ベクトル信号アナライザーの市場概観 ・ベクトル信号アナライザーの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ベクトル信号アナライザーの企業別販売動向、市場シェア、市場集中度、競争動向 ・ベクトル信号アナライザーの世界市場規模 ・ベクトル信号アナライザーの北米市場分析（アメリカ、カナダ、メキシコ等） ・ベクトル信号アナライザーのアメリカ市場規模推移 ・ベクトル信号アナライザーのカナダ市場規模推移 ・ベクトル信号アナライザーのメキシコ市場規模推移 ・ベクトル信号アナライザーのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...A vector signal analyzer is an instrument that measures the magnitude and phase of the input signal at a single frequency within the IF bandwidth of the instrument. The primary use is to make in-channel measurements, such as error vector magnitude, code domain power, and spectral flatness, on known signals. Scope of the Report: The worldwide market for Vector Signal Analyzer is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report...
  • 新興癌ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103455 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、新興癌ワクチンの世界市場について調べ、まとめました。種類別セグメントは、非遺伝子ワクチン、遺伝子ワクチン等、用途別セグメントは、がん研究センター、がん病院、クリニック、その他等に区分しました。新興癌ワクチンの世界市場概観、メーカー動向、メーカー別新興癌ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・新興癌ワクチンの市場概観 ・新興癌ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・新興癌ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・新興癌ワクチンの世界市場規模 ・新興癌ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・新興癌ワクチンのアメリカ市場規模推移 ・新興癌ワクチンのカナダ市場規模推移 ・新興癌ワクチンのメキシコ市場規模推移 ・新興癌ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Genetic vaccines are emerging as promising methodologies to elicit immune responses against a wide variety of antigens. Scope of the Report: The worldwide market for Emerging Cancer Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Emerging Cancer Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and...
  • オーエスキー病ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100289 / GlobalInfoResearch / 2019年10月10日 / 本調査レポートは、オーエスキー病ワクチンの世界市場について調べ、まとめました。種類別セグメントは、凍結乾燥錠、注射剤等、用途別セグメントは、雌ブタ、子ブタ、イノシシ等に区分しました。オーエスキー病ワクチンの世界市場概観、メーカー動向、メーカー別オーエスキー病ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・オーエスキー病ワクチンの市場概観 ・オーエスキー病ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・オーエスキー病ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・オーエスキー病ワクチンの世界市場規模 ・オーエスキー病ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・オーエスキー病ワクチンのアメリカ市場規模推移 ・オーエスキー病ワクチンのカナダ市場規模推移 ・オーエスキー病ワクチンのメキシコ市場規模推移 ・オーエスキー病ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Aujeszky Disease Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Aujeszky Disease Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Zendal group(CZ Vaccines) Kyoritsuseiyaku Corporation Ceva IDEXX MSD Animal...

    • ◆H&Iグローバルリサーチのお客様（例）◆